Markets:

Overview

News

Currencies

International

Treasuries

Pressure Biosciences Inc (OP:PBIO)

0.0012 +0.0006 (+100.00%)

Streaming Delayed Price Updated: 1:08 PM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pressure Biosciences Inc

< Previous 1 2 Next >

Toni Braxton Cheers PBIO's Acquisition Of Cannabis And Hemp Co. Uncle Bud's ↗

January 15, 2024

Pressure BioSciences, Inc. (OTC: PBIO), a company focused on pressure-based instruments and services for the cannabis industry, has announced a definitive agreement to acquire Uncle Bud’s, a natural...

Via Benzinga

Topics Cannabis

CBD To Extend Shelf-Life Of Fresh Produce? This Company Is Working On It ↗

July 25, 2023

Pressure BioSciences, Inc. (OTCQB: PBIO) announced today the initiation of studies to evaluate and demonstrate its industrially-scalable UltraShear Technology platform for producing oil-in-water...

Via Benzinga

Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux ↗

May 09, 2023

Often considered recession-proof, the life sciences sector faced a surprising amount of uncertainty over the past few years with up to 80% of companies saying they’ve been negatively impacted by the...

Via Benzinga

CBD Oil's Health Benefits Are Reportedly Locked Behind Poor Absorption Rates — This Pressure-Based Tech Company Says It's Found The Key ↗

May 04, 2023

As the cannabis market moves steadily toward widespread legalization and acceptance, cannabidiol (CBD), one of the key medicinal compounds derived from the hemp plant, is appearing as an ingredient in...

Via Benzinga

Pressure BioSciences Wins $1.5 Million Contract From CBD Supply MD To Bring A Potent Nano-CBD Topical Spray To Store Shelves In April ↗

April 25, 2023

This week, Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO”) announced that it had received a $1.5 million contract for its breakthrough CBD nanoemul

Via Benzinga

Conversion Of $10 Million Of Debt Into Equity Bolsters Pressure BioSciences's Balance Sheet, Signals Confidence In Plan To Transition To Profitability ↗

April 20, 2023

Earlier in March, Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”) announced that its largest shareholder has converted $10 million of secured d

Via Benzinga

One World Pharma's NBA Legend Isiah Thomas Is Creating CBD-Infused Sports Performance/Recovery Drink, Tapping Power Of Pressure BioSciences Nanoemulsions To Amplify Absorption Rates ↗

April 18, 2023

A line of next-generation sports drinks infused with CBD and antioxidant nanoemulsions is set to come to market soon, thanks to a collaboration agreement announced in January between leading cannabis...

Via Benzinga

Isiah Thomas: From NBA Champ To Business Mogul, Hemp Cars, CBD Drinks & Champagne Producer ↗

March 16, 2023

NBA Hall of Famer and sports legend-turned-cannabis entrepreneur Isiah Thomas knows how to make his dreams come to life.

Via Benzinga

Pressure BioSciences’ Breakthrough UltraShear Nanoemulsion Processing Could Help Revolutionize The Edible Cannabis Industry

February 24, 2023

Pressure BioSciences’ Breakthrough UltraShear Nanoemulsion Processing Could Help Revolutionize The Edible Cannabis Industry

Via News Direct

Topics Cannabis

Pressure BioSciences' Breakthrough UltraShear Nanoemulsion Processing Could Help Revolutionize The Edible Cannabis Industry ↗

February 23, 2023

Earlier this month, Pressure BioSciences, Inc. (OTCQB: PBIO) announced potentially ground-breaking results from a consumer focus group testing a

Via Benzinga

These Companies Teamed Up To Develop CBD-Nanoemulsion Sports Performance/Recovery Drinks ↗

January 27, 2023

Pressure BioSciences, Inc. (OTCQB: PBIO) and One World Products, Inc. (OTCQB: OWPC) have entered into an active collaboration agreement under which the two companies will combine their strong

Via Benzinga

Is Getting High In 10 Minutes Without The Respiratory Health Risks Possible? Company Clams It Is With New THC Oral Spray ↗

January 19, 2023

Pressure BioSciences, Inc. (OTCQB: PBIO) announced results from initial consumer focus group testing of a THC Nanoemulsion Oral Spray prepared using PBI's Ultra Shear Technology platform.

Via Benzinga

25 Penny Stocks to Sell Before They Die ↗

December 07, 2022

Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.

Via InvestorPlace

7 Stocks to Sell Right Now… and 1 to Buy ↗

November 18, 2022

Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell.

Via InvestorPlace

Pressure Biosciences Secures Partnership With Dr. Denese SkinScience, A 20-Year Leader In Cosmeceuticals With Over $500 Million In Sales ↗

August 24, 2022

Pressure BioSciences Inc.

Via Benzinga

EXCLUSIVE: Pressure BioSciences Inks Cosmeceuticals Partnership Using Nano Emulsification Platform ↗

August 24, 2022

Pressure BioSciences Inc (OTC: PBIO) has teamed up with Dr. Adrienne Denese for a two-year Collaborative Research and Development Agreement.

Via Benzinga

Pressure BioSciences Signs Multi-Year Manufacturing Agreement; To Be First Product Commercially Sold Into Consumer Market Containing UST-Produced Nanoemulsion ↗

May 05, 2022

Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program ↗

May 04, 2022

Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain Reduction

Via Benzinga

SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference ↗

April 27, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

PBI Recently Installed Its Commercial Scale Nanoemulsion Tech For "Safer, Healthier Foods And Beverages" at Ohio State's Renowned Advanced Food Technology Pilot Plant ↗

April 21, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference ↗

April 19, 2022

Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20th at 10:30am EDT

Via Benzinga

Novel Ultra High-Pressure, Intense Shear System Aims To Improve Food Quality And Safety ↗

April 04, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Pressure BioSciences Updates Stakeholders With Solid Progress On Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market ↗

March 17, 2022

Company Reports Record Instrument Orders in March, Expands BaroFold Platform Services, Builds Strong Demand for Initial UST Tolling Services, and Prepares Foundation for Uplisting

Via Benzinga

Ohio State Installs, Commissions New Pilot-Scale Ultra Shear Technology Processing Equipment for Preparation of Higher Quality and Safer Liquid Foods and Beverages ↗

March 03, 2022

Columbus, Ohio, March 3, 2022 – Food processing companies looking for innovative new ways to preserve clean-label liquid food without artificial preservatives will soon have a new option to do so...

Via Benzinga

This Company's 18-Month CBD Stability Achievement Could Hint Towards Expansion Goals As It Plans To Release First Commercial UST System In 2022 ↗

February 10, 2022

Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Does This Company's Recent CBD Breakthrough Earn It A Spot In The Guinness World Records? ↗

February 04, 2022

Photo by CBD Infos on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Pressure BioSciences Ultra Shear Technology Commercialization Achieves Key Milestone: Production-Scale System Commissioned At Ohio State To Serve Food Industry ↗

January 27, 2022

Installation of BaroShear MAX UST System in Acclaimed The Ohio State University Food Pilot Plant Will Introduce Global Food Industry to Preparation of Safer, More Nutritious...

Via Benzinga

Pressure BioSciences to Participate in FORCE Family Office's January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market ↗

January 20, 2022

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Fireside Chat South Easton, MA, January 19, 2022 – Pressure BioSciences, Inc. (OTCQB:...

Via Benzinga

This Company Believes Physics, Not Chemistry, Is the Best Way To Develop Successful Protein Therapeutics ↗

January 13, 2022

Picture credit: Michael Longmire on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing...

Via Benzinga

Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability ↗

December 22, 2021

UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets South Easton, MA, December 22, 2021 – Pressure BioSciences, Inc. (...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.